Shear wave elastography for differentiating benign and malignant ovarian masses
Bioinformation · 31.10.2026 · 22 (10) · 7243-7247
DOI: 10.6026/973206300227243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, erschienen am 31.10.2026. Verfasst von Prakhar Srivastava.
Abstract (Originalsprache)
Accurate pre-operative differentiation of benign and malignant ovarian masses is essential for appropriate surgical planning and fertility preservation. Therefore, it is of interest to evaluate the diagnostic value of shear wave elastography (SWE) in 109 women with ovarian masses using histopathology as the reference standard. Histopathology identified 68 benign and 41 malignant masses, with significantly higher stiffness in malignant lesions (48.35 +/- 8.74 vs 25.41 +/- 5.76 kPa; p < 0.001). At a 35.3-kPa cutoff, SWE achieved an AUC of 0.980, sensitivity of 95.1%, specificity of 97.1%, and accuracy of 96.3%. Thus, incorporating SWE into conventional ultrasonography improved diagnostic accuracy and may support more precise pre-operative assessment of ovarian masses.
Zitieren
APA
Srivastava, P. (2026). Shear wave elastography for differentiating benign and malignant ovarian masses. Bioinformation, 22(10), 7243-7247. https://doi.org/10.6026/973206300227243
Vancouver
Srivastava P. Shear wave elastography for differentiating benign and malignant ovarian masses. Bioinformation. 2026;22(10):7243-7247. doi:10.6026/973206300227243
BibTeX
@article{Srivastava2026,
author = {Srivastava, Prakhar},
title = {Shear wave elastography for differentiating benign and malignant ovarian masses},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7243--7247},
doi = {10.6026/973206300227243}
}
EUVIMED